Is Revolution Medicines a Good Stock to Own?
Though it’s still quite early in the year, pharmaceutical startup…
Sell
39
LFWD Quote, Financials, Valuation and Earnings
Last price:
$0.67
Seasonality move
:
-8.21%
Day range:
$0.66 - $0.73
52-week range:
$0.50 - $2.95
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
0.31x
P/B ratio:
0.91x
Volume:
394.9K
Avg. volume:
757K
1-year change:
-55.11%
Market cap:
$11.6M
Revenue:
$25.7M
EPS (TTM):
-$2.98
Analysts' Opinion
-
Consensus RatingLifeward Ltd. has received a consensus rating of Buy. The company's average rating is a Buy based on 1 Buy rating, 0 Hold ratings, and 0 Sell ratings.
-
Price Target UpsideAccording to analysts' consensus price target of $7.25, Lifeward Ltd. has an estimated upside of 1006.2% from its current price of $0.66.
-
Price Target DownsideAccording to analysts, the lowest downside price target is $4.50 representing 100% downside risk from its current price of $0.66.
Fair Value
-
According to the consensus of 1 analyst, Lifeward Ltd. has 1006.2% upside to fair value with a price target of $7.25 per share.
LFWD vs. S&P 500
-
Over the past 5 trading days, Lifeward Ltd. has overperformed the S&P 500 by 3.76% suggesting its relative strength compared to the major market average is strong at this time.
Share Buyback
-
Lifeward Ltd. does have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.
Revenue Growth
-
Lifeward Ltd. has grown year-over-year revenues for 1 quarter straight. In the most recent quarter Lifeward Ltd. reported revenues of $6.2M.
Earnings Growth
-
Lifeward Ltd. has grown year-over-year earnings for 1 quarter straight. In the most recent quarter Lifeward Ltd. reported earnings per share of -$0.20.
Enterprise value:
9.7M
EV / Invested capital:
--
Price / LTM sales:
0.31x
EV / EBIT:
--
EV / Revenue:
0.39x
PEG ratio (5yr expected):
-0.01x
EV / Free cash flow:
-0.56x
Price / Operating cash flow:
--
Enterprise value / EBITDA:
--
Gross Profit (TTM):
$9.2M
Return On Assets:
-96.26%
Net Income Margin (TTM):
-121.82%
Return On Equity:
-150.63%
Return On Invested Capital:
-146.07%
Operating Margin:
-50.69%
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2023-09-30 | 2024-09-30 | 2025-09-30 | 2024-09-30 | 2025-09-30 | |
| Income Statement | ||||||
| Revenue | $9.1M | $25M | $24.5M | $6.1M | $6.2M | |
| Gross Profit | $2.4M | $6.9M | $9.2M | $1.7M | $2.7M | |
| Operating Income | -$22.5M | -$19.6M | -$17.2M | -$3.2M | -$3.1M | |
| EBITDA | -$21.5M | -$15.8M | -$16M | -$2.2M | -$3.1M | |
| Diluted EPS | -$2.54 | -$2.24 | -$2.98 | -$0.35 | -$0.20 | |
| Period Ending | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2025-09-30 | |
|---|---|---|---|---|---|---|
| Balance Sheet | ||||||
| Current Assets | $96.3M | $78.9M | $44.4M | $25.6M | $17.3M | |
| Total Assets | $98.7M | $80.8M | $69.2M | $45.8M | $23.2M | |
| Current Liabilities | $4.4M | $4.2M | $12.8M | $9.7M | $9.1M | |
| Total Liabilities | $5.7M | $5.2M | $17.4M | $11.9M | $10.4M | |
| Total Equity | $93M | $75.6M | $51.8M | $33.9M | $12.8M | |
| Total Debt | $535K | $85K | $856K | $45K | $88K | |
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2023-09-30 | 2024-09-30 | 2025-09-30 | 2024-09-30 | 2025-09-30 | |
| Cash Flow Statement | ||||||
| Cash Flow Operations | -$20.1M | -$22.2M | -$17.2M | -$4.5M | -$3.8M | |
| Cash From Investing | -$18.1M | -$79K | -$5K | -- | -- | |
| Cash From Financing | -$3.3M | -- | $8.4M | -- | $646K | |
| Free Cash Flow | -$20.1M | -$22.3M | -$17.2M | -$4.5M | -$3.8M | |
LFWD
Sector
Market Cap
$11.6M
$27.1M
Price % of 52-Week High
22.22%
51.93%
Dividend Yield
0%
0%
Shareholder Yield
-68.46%
-1.63%
1-Year Price Total Return
-55.11%
-15.41%
Beta (5-Year)
0.002
0.489
Dividend yield:
0%
Annualized payout:
$0.00
Payout ratio:
--
Growth streak:
0 years
Technicals
8-day SMA
Buy
Level
$0.64
200-day SMA
Sell
Level
$0.87
Bollinger Bands (100)
Buy
Level
0.56 - 0.72
Chaikin Money Flow
Sell
Level
-131.6M
20-day SMA
Buy
Level
$0.64
Relative Strength Index (RSI14)
Buy
Level
52.49
ADX Line
Buy
Level
15.88
Williams %R
Neutral
Level
-46.5977
50-day SMA
Buy
Level
$0.62
MACD (12, 26)
Sell
Level
0.00
25-day Aroon Oscillator
Sell
Level
-56
On Balance Volume
Neutral
Level
186.2M
Financial Scores
Sell
Altman Z-Score
(Annual)
Level (-12.2145)
Sell
CA Score
(Annual)
Level (-1.2245)
Buy
Beneish M-Score
(Annual)
Level (-3.1769)
Sell
Momentum Score
Level (1)
Sell
Ohlson Score
Level (6.1693)
Buy
Piotroski F Score
(Annual)
Level (4)
Buy
Quality Ratio Score
Level (7)
Buy
Fundamental Score
Level (3)
Revenue Forecast
Earnings per Share Forecast
Company Profile
Lifeward Ltd. is a medical device company, which engages in the design, development and marketing of wearable robotic exoskeletons. The firm's exoskeletons provide hip and knee motion to enable individuals with spinal cord injury (SCI) to stand upright, walk, turn, and climb and descend stairs. Its products include ReWalk Exo-Suit and ReWalk Personal 6.0. The company was founded by Amit Goffer on June 20, 2001 and is headquartered in Marlborough, MA.
Stock Forecast FAQ
In the current month, LFWD has received 1 Buy ratings 0 Hold ratings, and 0 Sell ratings. The LFWD average analyst price target in the past 3 months is $7.25.
-
Where Will Lifeward Ltd. Stock Be In 1 Year?
According to analysts, the consensus estimate is that Lifeward Ltd. share price will rise to $7.25 per share over the next 12 months.
-
What Do Analysts Say About Lifeward Ltd.?
Analysts are divided on their view about Lifeward Ltd. share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that Lifeward Ltd. is a Sell and believe this share price will drop from its current level to $4.50.
-
What Is Lifeward Ltd.'s Price Target?
The price target for Lifeward Ltd. over the next 1-year time period is forecast to be $7.25 according to 1 Wall Street analyst, 1 of them rates the stock a Buy, 0 rate the stock a Sell, and 0 analysts rate the stock a Hold.
-
Is LFWD A Buy, Sell Or Hold?
According to Wall Street analysts, the consensus rating for Lifeward Ltd. is a Buy. 1 of 1 analysts rates the stock a Buy at this time.
-
How Can I Buy Shares Of LFWD?
You can purchase shares of Lifeward Ltd. via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase Lifeward Ltd. shares.
-
What Is The Lifeward Ltd. Share Price Today?
Lifeward Ltd. was last trading at $0.67 per share. This represents the most recent stock quote for Lifeward Ltd.. Yesterday, Lifeward Ltd. closed at $0.66 per share.
-
How To Buy Lifeward Ltd. Stock Online?
In order to purchase Lifeward Ltd. stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.
Get LFWD Stock Alert
Signup to receive the latest stock alerts
Financial Ratios
LFWD
Sector
P/E ratio
--
23.89x
PEG ratio
-0.01x
-0.01x
P/B ratio
0.91x
1.82x
Price / LTM sales
0.31x
1.60x
Growth Metrics
LFWD
Sector
Revenue growth
1.09%
4.35%
Earnings growth
43.81%
9.95%
Revenue (5-year growth)
39.41%
6.41%
Earnings forecast
-$0.09
-$0.18
Profitability
LFWD
Sector
Profitability FY 2024
$8.2M
$3.4M
Return on invested capital
-146.07%
-32.69%
Return on assets
-96.26%
-29%
Return on equity
-150.63%
-38.43%
Earnings Date
Last Earnings Date
Nov
14
Next Earnings Date
Mar
5
Estimated Next Earnings Date
Feb
13
Balance Sheet
LFWD
Sector
Total cash
$2.2M
$25.7M
Short term investments
--
$25.5M
Total assets
$30.5M
$75.6M
Long term debt
$88K
$3.2M
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Why Has Vistra Stock Gone Up?
Integrated power generation business Vistra (NYSE:VST) surprised investors recently when…
Why Is Amkor Stock Up So Much?
Semiconductor packaging and testing major Amkor (NASDAQ:AMKR) has started 2026…
Stock Ideas
Buy
51
Is NVDA Stock a Buy?
Market Cap: $4.5T
P/E Ratio: 62x
Buy
67
Is GOOG Stock a Buy?
Market Cap: $4.1T
P/E Ratio: 42x
Buy
53
Is GOOGL Stock a Buy?
Market Cap: $4.1T
P/E Ratio: 42x
Alerts
Buy
80
BNR alert for Jan 15
Burning Rock Biotech Ltd. [BNR] is up 11.92% over the past day.
Sell
37
TCOM alert for Jan 15
Trip.com Group Ltd. [TCOM] is down 2.66% over the past day.
Sell
39
DAVE alert for Jan 15
Dave, Inc. [DAVE] is up 3.64% over the past day.
THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS
Show me the best stock
